JOINT FILING AGREEMENTJoint Filing Agreement • December 30th, 2019 • Vivo Capital IX, LLC • Pharmaceutical preparations
Contract Type FiledDecember 30th, 2019 Company IndustryIn accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, $0.0001 par value, of Selecta Biosciences, Inc., and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filing.